Formulary Monographs [MOCLOBEMIDE, 28160412]
|
|
MOCLOBEMIDE
|
|
|
|
|
|
MONOAMINE OXIDASE INHIBITORS
|
|
|
Depression, social anxiety disorder.
|
|
|
Sleep disturbances, dizziness, agitation, feelings of anxiety , restlessness, irritability, headache.
|
|
|
Adult: Depression: Initially 300 mg daily in divided doses,
adjusted according to response; usual dose 150–600 mg daily after a meal.Anxiety: Initially 300 mg daily for 3 days, then increased to 600 mg daily in 2 divided doses continued for 8-12 weeks to |
|
|
|
|
|
|
|
|
|
|
|
|